Free Trial

Relay Therapeutics (RLAY) SEC Filings & 10K Form

Relay Therapeutics logo
$4.16 -0.10 (-2.35%)
(As of 12/20/2024 05:45 PM ET)

Recent Relay Therapeutics SEC Filings

DateFilerForm TypeView
12/16/2024
3:18 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:07 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:08 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:05 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:45 PM
Relay Therapeutics (Filer)
Form 424B5
09/11/2024
3:49 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:43 PM
Relay Therapeutics (Filer)
Form 424B5
09/09/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:23 PM
Relay Therapeutics (Filer)
Form S-3ASR
08/06/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:42 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:06 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:37 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:24 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:29 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:47 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:05 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:15 PM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:38 PM
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:18 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
7:00 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:01 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:02 PM
HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM
INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM
Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Relay Therapeutics (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM
Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:12 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

05/02/2024
3:15 PM
Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:30 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:31 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:33 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:36 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:05 PM
Relay Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Relay Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:15 PM
Relay Therapeutics (Filer)
Form ARS
03/29/2024
3:15 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:15 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:34 PM
Relay Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
3:16 PM
Relay Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
3:11 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:35 AM
Relay Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:25 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:10 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:13 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:16 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
3:19 PM
Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
8:22 AM
Relay Therapeutics (Filer)
Form 424B7
01/10/2024
8:14 AM
Relay Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/08/2024
6:05 AM
Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:22 PM
Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:26 PM
Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:14 PM
Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:17 PM
Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RLAY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners